128 related articles for article (PubMed ID: 22160580)
1. Spin electron paramagnetic resonance of albumin for diagnosis of oral squamous cell carcinoma (OSCC).
Moergel M; Kämmerer PW; Schnurr K; Klein MO; Al-Nawas B
Clin Oral Investig; 2012 Dec; 16(6):1529-33. PubMed ID: 22160580
[TBL] [Abstract][Full Text] [Related]
2. Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oral squamous cell carcinoma.
Tan Y; Yan B; Xue L; Li Y; Luo X; Ji P
Lipids Health Dis; 2017 Apr; 16(1):73. PubMed ID: 28388900
[TBL] [Abstract][Full Text] [Related]
3. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
[TBL] [Abstract][Full Text] [Related]
4. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
5. Serum Annexin A2 Level Is Associated With Diagnosis and Prognosis in Patients With Oral Squamous Cell Carcinoma.
Zhang W; Gao C; Zhang S; Fang G
J Oral Maxillofac Surg; 2017 May; 75(5):1081-1087. PubMed ID: 27889534
[TBL] [Abstract][Full Text] [Related]
6. Circulating high mobility group AT-hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma.
Ren W; Gao L; Li F; Qiang C; Li S; Zheng J; Kong X; Deng J; Cai G; Zhang H; Zhou M; Zhi K
J Oral Pathol Med; 2017 Nov; 46(10):998-1003. PubMed ID: 28650082
[TBL] [Abstract][Full Text] [Related]
7. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
Jiang T; Liu G; Wang L; Liu H
PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
[TBL] [Abstract][Full Text] [Related]
8. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
9. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
[TBL] [Abstract][Full Text] [Related]
10. Host Factors Independently Associated With Prognosis in Patients With Oral Cavity Cancer.
Valero C; Zanoni DK; Pillai A; Ganly I; Morris LGT; Shah JP; Wong RJ; Patel SG
JAMA Otolaryngol Head Neck Surg; 2020 Aug; 146(8):699-707. PubMed ID: 32525545
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
12. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pretreatment serum interleukin-6 and tumour necrosis factor alpha as a potential biomarker for recurrence in patients with oral squamous cell carcinoma.
Skrinjar I; Brailo V; Vidovic-Juras D; Vucicevic-Boras V; Milenovic A
Med Oral Patol Oral Cir Bucal; 2015 Jul; 20(4):e402-7. PubMed ID: 25858079
[TBL] [Abstract][Full Text] [Related]
14. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
15. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
16. The altered expression levels of miR-186, miR-494 and miR-3651 in OSCC tissue vary from those of the whole blood of OSCC patients.
Ries J; Baran C; Wehrhan F; Weber M; Motel C; Kesting M; Nkenke E
Cancer Biomark; 2019; 24(1):19-30. PubMed ID: 30594916
[TBL] [Abstract][Full Text] [Related]
17. Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma.
Ding L; Li B; Zhao Y; Fu YF; Hu EL; Hu QG; Ni YH; Hou YY
Tumour Biol; 2014 Oct; 35(10):10539-46. PubMed ID: 25060177
[TBL] [Abstract][Full Text] [Related]
18. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma?
Shukla D; Kale AD; Hallikerimath S; Yerramalla V; Subbiah V
J Oral Maxillofac Surg; 2013 Feb; 71(2):414-8. PubMed ID: 22749518
[TBL] [Abstract][Full Text] [Related]
19. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
Xie J; Li Y; Kong J; Li C
J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690
[TBL] [Abstract][Full Text] [Related]
20. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.
Chang PY; Kuo YB; Wu TL; Liao CT; Sun YC; Yen TC; Chan EC
Clin Chem Lab Med; 2013 Jun; 51(6):1291-300. PubMed ID: 23154424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
